Can extra cholesterol-lowering help after a stent?
Part of Heart & circulation clinical trials.
This trial looks at whether stronger cholesterol-lowering medicine can reduce the risk of future heart problems in people who already have a stent. It focuses on people who still have other mildly narrowed spots in their arteries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart disease and have had a successful stent placement (angioplasty) to open a blocked artery.
- You have other narrowed areas (20–50% blocked) near the stent that can be clearly seen on an angiogram (X-ray of your arteries).
- Your age is between 18 and 75.
- You do not have an autoimmune disease or take immune-suppressing drugs.
- You do not have a genetic condition called familial hypercholesterolemia (very high inherited cholesterol).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
This trial tests whether a single injection of a PCSK9 inhibitor (a cholesterol-lowering medicine) can improve heart health after a stent procedure. It is for people who have a certain amount of fat buildup in their treated artery.
This study is testing whether reaching a very low LDL cholesterol level (below 1.0 mmol/L) is better than a slightly higher target (1.0-1.8 mmol/L) for people at very high risk after receiving a heart stent. It aims to reduce future heart problems.
This study compares two ways to lower cholesterol and stabilize artery plaque in people with coronary artery disease who are having a stent procedure. It tests whether a moderate statin plus ezetimibe works as well as a high-intensity statin alone for stabilizing plaque.
This trial tests whether higher doses of cholesterol-lowering medication (statins) can slow down plaque buildup in the heart arteries of younger and middle-aged adults with stable chest pain. It may help prevent heart attacks and the need for procedures like stents.
This study looks at whether choosing blood thinners based on each person's needs works better than a standard approach after getting a heart stent. It aims to reduce risks like blood clots or bleeding.
Hear when a new Coronary Heart Disease (CHD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.